182 related articles for article (PubMed ID: 31321524)
1. PEG vs. sennosides for opioid-induced constipation in cancer care.
Hawley P; MacKenzie H; Gobbo M
Support Care Cancer; 2020 Apr; 28(4):1775-1782. PubMed ID: 31321524
[TBL] [Abstract][Full Text] [Related]
2. A Randomized, Multicenter, Prospective, Crossover, Open-Label Study of Factors Associated With Patient Preferences for Naloxegol or PEG 3350 for Opioid-Induced Constipation.
Brenner DM; Hu Y; Datto C; Creanga D; Camilleri M
Am J Gastroenterol; 2019 Jun; 114(6):954-963. PubMed ID: 31058652
[TBL] [Abstract][Full Text] [Related]
3. Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).
Gordon M; Naidoo K; Akobeng AK; Thomas AG
Evid Based Child Health; 2013 Jan; 8(1):57-109. PubMed ID: 23878124
[TBL] [Abstract][Full Text] [Related]
4. A comparison of sennosides-based bowel protocols with and without docusate in hospitalized patients with cancer.
Hawley PH; Byeon JJ
J Palliat Med; 2008 May; 11(4):575-81. PubMed ID: 18454610
[TBL] [Abstract][Full Text] [Related]
5. Laxative management in ambulatory cancer patients on opioid therapy: a prospective, open-label investigation of polyethylene glycol, sodium picosulphate and lactulose.
Wirz S; Nadstawek J; Elsen C; Junker U; Wartenberg HC
Eur J Cancer Care (Engl); 2012 Jan; 21(1):131-40. PubMed ID: 21880080
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis.
Cobo Dols M; Beato Zambrano C; Cabezón Gutiérrez L; Chicas Sett R; Blancas López-Barajas MI; García Navalón F; Fírvida Pérez JL; Serrano Bermúdez G; Togores Torres P; Delgado Mingorance I; Giraldo Marín A; Librán Oriol A; Paredes Lario A; Sánchez Mauriño P; Higuera Gómez O; Moreno Muñoz D; Jiménez López AJ; Huerta González I; Sanz Yagüe A; Soler López B
BMJ Support Palliat Care; 2021 Mar; 11(1):25-31. PubMed ID: 32376758
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and side-effect profiles of lactulose, docusate sodium, and sennosides compared to PEG in opioid-induced constipation: a systematic review.
Ruston T; Hunter K; Cummings G; Lazarescu A
Can Oncol Nurs J; 2013; 23(4):236-46. PubMed ID: 24428006
[TBL] [Abstract][Full Text] [Related]
8. Magnesium hydroxide versus macrogol/electrolytes in the prevention of opioid-induced constipation in incurable cancer patients: study protocol for an open-label, randomized controlled trial (the OMAMA study).
Kistemaker KRJ; de Graeff A; Crul M; de Klerk G; van de Ven PM; van der Meulen MP; van Zuylen L; Steegers MAH
BMC Palliat Care; 2023 Mar; 22(1):22. PubMed ID: 36915062
[TBL] [Abstract][Full Text] [Related]
9. Challenges in Recruiting Patients to a Controlled Feasibility Study of a Drug for Opioid-Induced Constipation: Lessons From the Population With Advanced Cancer.
Bull J; Bonsignore L; Massie L; Riggs A; Knotkova H; Wellman C; Portenoy R
J Pain Symptom Manage; 2019 May; 57(5):e5-e8. PubMed ID: 30853551
[No Abstract] [Full Text] [Related]
10. Efficacy and tolerability of peg-only laxative on faecal impaction and chronic constipation in children. A controlled double blind randomized study vs a standard peg-electrolyte laxative.
Savino F; Viola S; Erasmo M; Di Nardo G; Oliva S; Cucchiara S
BMC Pediatr; 2012 Nov; 12():178. PubMed ID: 23152962
[TBL] [Abstract][Full Text] [Related]
11. Osmotic and stimulant laxatives for the management of childhood constipation.
Gordon M; Naidoo K; Akobeng AK; Thomas AG
Cochrane Database Syst Rev; 2012 Jul; (7):CD009118. PubMed ID: 22786523
[TBL] [Abstract][Full Text] [Related]
12. Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation -- a comparison in a controlled environment.
Cinca R; Chera D; Gruss HJ; Halphen M
Aliment Pharmacol Ther; 2013 May; 37(9):876-86. PubMed ID: 23480216
[TBL] [Abstract][Full Text] [Related]
13. Small volume isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in treatment of chronic nonorganic constipation.
Corazziari E; Badiali D; Habib FI; Reboa G; Pitto G; Mazzacca G; Sabbatini F; Galeazzi R; Cilluffo T; Vantini I; Bardelli E; Baldi F
Dig Dis Sci; 1996 Aug; 41(8):1636-42. PubMed ID: 8769292
[TBL] [Abstract][Full Text] [Related]
14. A comparison of polyethylene glycol laxative and placebo for relief of constipation from constipating medications.
DiPalma JA; Cleveland MB; McGowan J; Herrera JL
South Med J; 2007 Nov; 100(11):1085-90. PubMed ID: 17984738
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Functional Characteristics of Nursing Facility Residents with Opioid-Induced Constipation.
Allen C; Zarowitz BJ; O'Shea T; Datto C; Olufade T
Consult Pharm; 2017 May; 32(5):285-298. PubMed ID: 28483009
[TBL] [Abstract][Full Text] [Related]
16. Medical Management of Opioid-Induced Constipation.
Rao VL; Micic D; Davis AM
JAMA; 2019 Dec; 322(22):2241-2242. PubMed ID: 31682706
[No Abstract] [Full Text] [Related]
17. Fixed ratio (2:1) prolonged-release oxycodone/naloxone combination improves bowel function in patients with moderate-to-severe pain and opioid-induced constipation refractory to at least two classes of laxatives.
Koopmans G; Simpson K; De Andrés J; Lux EA; Wagemans M; Van Megen Y
Curr Med Res Opin; 2014 Nov; 30(11):2389-96. PubMed ID: 25265132
[TBL] [Abstract][Full Text] [Related]
18. The impact of naloxegol on anal sphincter function - Using a human experimental model of opioid-induced bowel dysfunction.
Grønlund D; Poulsen JL; Krogh K; Brock C; Liao D; Gregersen H; Drewes AM; Olesen AE
Eur J Pharm Sci; 2018 May; 117():187-192. PubMed ID: 29432808
[TBL] [Abstract][Full Text] [Related]
19. Role of polyethylene glycol in childhood constipation.
Phatak UP; Pashankar DS
Clin Pediatr (Phila); 2014 Sep; 53(10):927-32. PubMed ID: 24108331
[TBL] [Abstract][Full Text] [Related]
20. Effect of an electronic medical record design modification on laxative co-prescribing among hospitalised patients taking opioids: A before-and-after study.
Liu S; Gnjidic D; Patanwala AE; Rubin G; Nielsen M; Penm J
Int J Med Inform; 2020 Aug; 140():104172. PubMed ID: 32473568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
